Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 18/20 | 0.50 |
| ▸ | ERBB2 | P04626 | 11/20 | 0.50 |
| ▸ | MAP1LC3B | Q9GZQ8 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.44 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16305164 | 0.95 | EGFR (0.53) | EGFRERBB2MAP1LC3BHDAC3HDAC4 | |
| SCHEMBL17327988 | 0.90 | EGFR (0.49) | EGFRERBB2MAP1LC3BHDAC3HDAC4 | |
| SCHEMBL16305160 | 0.89 | EGFR (0.53) | EGFRERBB2MAP1LC3BHDAC3HDAC4 | |
| SCHEMBL16297199 | 0.88 | EGFR (0.53) | EGFRERBB2MAP1LC3BHDAC3HDAC4 | |
| SCHEMBL17328019 | 0.83 | EGFR (0.53) | EGFRERBB2HDAC3HDAC4HDAC1 | |
| SCHEMBL17328028 | 0.83 | EGFR (0.53) | EGFRERBB2HDAC3HDAC4HDAC1 | |
| SCHEMBL16305142 | 0.76 | TSHR (0.48) | — | |
| SCHEMBL16294776 | 0.72 | TSHR (0.44) | — | |
| SCHEMBL16296741 | 0.68 | TSHR (0.63) | — | |
| SCHEMBL17327980 | 0.68 | EGFR (0.70) | EGFRERBB2HDAC3HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014200872-A9 | PHARMACEUTICAL COMPOUNDS TARGETED BY MIF AFFINITY-TETHERED MOIETIES | RJS BIOLOGICS LLC (US) | 2015-02-05 | — | — | WO | disclosed |
| WO-2014200872-A1 | PHARMACEUTICAL COMPOUNDS TARGETED BY MIF AFFINITY-TETHERED MOIETIES | RJS BIOLOGICS LLC (US) | 2014-12-18 | — | — | WO | disclosed |